Saqib Islam - Jun 4, 2021 Form 4 Insider Report for Silverback Therapeutics, Inc. (SPRY)

Role
Director
Signature
/s/ Jeffrey C. Pepe, Attorney-in-Fact
Stock symbol
SPRY
Transactions as of
Jun 4, 2021
Transactions value $
$0
Form type
4
Date filed
9/21/2021, 05:06 PM
Previous filing
May 28, 2021
Next filing
Jul 20, 2021

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SPRY Stock Option (right to buy) Award $0 +15K $0.00 15K Jun 4, 2021 Common Stock 15K $28.83 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares subject to the option vest on the earlier of June 4, 2022 or the date of the 2022 annual meeting of the Issuer's stockholders which date has not been set by the Issuer's Board of Directors.